BRAF and colorectal carcinoma: In the case of small bowel cancer, which was the second most common non-CRC GI malignancy to have a BRAF mutation in this study, an incidence of 4.0% was detected, which is lower than a prior report suggesting a frequency of approximately 9% [20].